Table 1.
Clinical characteristics of strongyloidiasis-associated nephropathy in the literature review
Author | Age, years/sex | Prior diagnosis of strongyloidiasis | Initial presenting symptoms | Duration of steroid use | Manifestations of strongyloidiasis | Kidney biopsy | Antihelmintic therapy | Outcome |
---|---|---|---|---|---|---|---|---|
Present case | 67/M | No | Generalized oedema | 1 month | Nausea, vomiting, diarrhoea | MCD | Ivermectin | Remission |
Miyazaki et al. [9], 2010 | 69/M | No | Generalized oedema | >4 months | Diarrhoea, weight loss | MCD | Ivermectin | Died |
Hsieh et al. [3], 2006 | 72/M | Yes | Cough, abdominal pain, diarrhoea | Nil | Presenting symptoms | MCD | Ivermectin | Remission |
Morimoto et al. [10], 2002 | 60/F | No | Generalized oedema | 2 months | Vomiting, paralytic ileus | MCD | - | Died |
Yee et al. [11], 1999 | 55/M | No | Generalized oedema | 6 weeks | Epigastralgia, vomiting, diarrhoea | MCD | Thiabendazole | Remission |
Wong et al. [12], 1998 | 42/F | No | Generalized oedema | 6 weeks | Brain abscess, gram-negative sepsis | (Biopsy done 4 months after treatment) | ||
MCD | Thiabendazole, albendazole | Remission | ||||||
Mori et al. [13], 1998 | 62/M | No | Generalized oedema | 1 month | Epigastralgia, paralytic ileus | MCD | Thiabendazole | Remission |
MCD, minimal change disease.